Vol 7 (April 30, 2026): Translational Breast Cancer Research

Can neoadjuvant chemotherapy be replaced with immune checkpoint blockade combined with dual anti-HER2 antibodies for HER2-enriched breast cancer?

Further considerations regarding the APHINITY statin analysis

Chinese Society of Clinical Oncology breast cancer expert consensus on the diagnosis and treatment of breast cancer brain metastasis (2025)

Clinical practice guidelines for prognosis and follow-up of early-stage breast cancer patients: Chinese Society of Breast Surgery (CSBrS) practice guidelines (2026 edition) Chinese Society of Breast Surgery, Chinese Society of Surgery, Chinese Medical Association

Chemotherapy-induced peripheral neuropathy in breast cancer: a narrative review

Radiotherapeutic management of brain metastases in patients with breast cancer: a narrative review

The impact of breast cancer on cosmetic breast augmentation outcomes and screening challenges in patients with implants: a literature review

Extent of resection in breast conserving surgery after neoadjuvant chemotherapy: a literature review

Magnetic resonance imaging in breast cancer management: current applications, limitations, and future directions

The efficacy and safety of metronomic vinorelbine combined with anlotinib in HER2-negative advanced breast cancer: a prospective, single-arm clinical study

Efficacy and safety of T-DXd in patients with HER2-positive and HER2-low metastatic breast cancer: a real-world study

Datopotamab deruxtecan in Chinese patients with heavily pretreated advanced or metastatic triple-negative breast cancer in the phase I/II TROPION-PanTumor02 study